MacroGenics
MGNX
#9151
Rank
S$0.14 B
Marketcap
S$2.33
Share price
-5.18%
Change (1 day)
-43.29%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): S-$0.09250

According to MacroGenics's latest financial reports the company's current EPS (TTM) is S-$0.06360. In 2024 the company made an earnings per share (EPS) of S-$1.36 a decrease over its 2023 EPS that were of S-$0.19.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.09250-93.2%
2024S-$1.36613.33%
2023S-$0.19-92.31%
2022S-$2.48-42.14%
2021S-$4.2936.44%
2020S-$3.14-21.84%
2019S-$4.02-24.58%
2018S-$5.33675.93%
2017S-$0.69-68.05%
2016S-$2.15168.25%
2015S-$0.80-55%
2014S-$1.783400%
2013S-$0.05088-108.68%
2012S$0.5924.49%
2011S$0.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$2.19-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$26.10-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$16.58-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$8.29-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.66-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.78-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S-$2.25 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA